Human ovarian tissue xenotransplantation: advancements, challenges, and future perspectives
Human Reproduction · 01.03.2025 · 40 (3) · 410-419
DOI: 10.1093/humrep/deae291 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Reproduction, online erschienen am 02.01.2025. Verfasst von Paweena Thuwanut und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Ovary, Fertility Preservation, Primary Ovarian Insufficiency. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Abstract (Originalsprache)
Ovarian tissue cryopreservation and transplantation has emerged as a promising fertility preservation technique for individuals facing premature ovarian insufficiency due to various medical conditions or treatments. Xenotransplantation, involving the transplantation of ovarian tissue into animal hosts, has played a pivotal role in refining ovarian tissue cryopreservation and transplantation techniques and addressing key challenges. This review provides a comprehensive overview of the current landscape of ovarian tissue xenotransplantation research, focusing on its applications in investigating ovarian biology, optimizing ovarian tissue cryopreservation and transplantation protocols, and assessing safety concerns. It also explores the utilization of xenografting of human ovarian tissue in mouse models in the last 10 years. Key findings from preclinical studies investigating grafting site optimization, cryopreservation protocol refinement, the development of strategies to mitigate chemotherapy-induced damage, follicle development, tissue revascularization, and the risk of malignant cell reintroduction are summarized. Moreover, the review examines the ethical considerations surrounding the use of animals in ovarian tissue xenotransplantation research and suggests emerging alternative models that aim to minimize animal use while maximizing clinical relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Animal Molecular and Cellular Biology, Louvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, Louvain-la-Neuve, Belgium.
- Department of Structural and Functional Biology, Institute of Biology, State University of Campinas, Campinas, São Paulo, Brazil.
- Pôle de Recherche en Physiopathologie de la Reproduction, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
- Laboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children, and Reproduction, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
ORCID-Profile: Stine Gry Kristensen, Christiani A Amorim
Zitieren
APA
Thuwanut, P., Leonel, E. C. R., Rocha Ruiz, T. F., Sirayapiwat, P., Kristensen, S. G., & Amorim, C. A. (2025). Human ovarian tissue xenotransplantation: advancements, challenges, and future perspectives. Human Reproduction, 40(3), 410-419. https://doi.org/10.1093/humrep/deae291
Vancouver
Thuwanut P, Leonel ECR, Rocha Ruiz TF, Sirayapiwat P, Kristensen SG, Amorim CA. Human ovarian tissue xenotransplantation: advancements, challenges, and future perspectives. Human Reproduction. 2025;40(3):410-419. doi:10.1093/humrep/deae291
BibTeX
@article{Thuwanut2025,
author = {Thuwanut, Paweena and Leonel, Ellen C R and Rocha Ruiz, Thalles Fernando and Sirayapiwat, Porntip and Kristensen, Stine Gry and Amorim, Christiani A},
title = {Human ovarian tissue xenotransplantation: advancements, challenges, and future perspectives},
journal = {Human Reproduction},
year = {2025},
volume = {40},
number = {3},
pages = {410--419},
doi = {10.1093/humrep/deae291}
}
EUVIMED